Results 161 to 170 of about 56,596 (269)

Treatment of pulmonary aspergilloma with itraconazole.

, 1991
In a 12 month open study of itraconazole in pulmonary aspergilloma nine patients received oral itraconazole 200 mg daily for six months followed by further itraconazole or observation for a further six months.
Banham, S W, Campbell, J H, Winter, J H, Shankland, G S, Richardson, M D   +4 more
core   +2 more sources

A Retrospective Analysis of Itraconazole and Hydroxy-Itraconazole Serum Concentrations Correlation to Clinical Outcomes of Histoplasmosis Treatment

Background: Itraconazole is the preferred antifungal agent for mild to moderate histoplasmosis and step-down therapy following amphotericin B treatment.
Joseph Herges, Kristin Cole, Paschalis Vergidis, Paul J. Jannetto, Mark J. Enzler, Ryan W. Stevens, Danielle Firkus, Meghan Haan, Christina G. Rivera, Omar M. Abu Saleh   +9 more
core   +1 more source

Trichophyton mentagrophytes Genotype VII: Sexually Transmitted Infection Beyond MSM

Australasian Journal of Dermatology, Volume 67, Issue 6, Page e365-e368, September 2026.
Gabriele Perego, Anna Grancini, Susanna Benardon, Stefano Ramoni, Angelo V. Marzano, Paolo Bortoluzzi   +5 more
wiley   +1 more source

Hidden Mould in the Air: A Practical Narrative Mini‐Review of Invasive Mould Infection Prevention for High‐Risk Patients and Clinicians

Mycoses, Volume 69, Issue 9, September 2026.
ABSTRACT Airborne mould spores, including those of the Aspergillus species, are ubiquitous both indoors and outdoors. While they are generally harmless, inhaled spores can cause severe infections, particularly invasive pulmonary aspergillosis, in patients with impaired immune defences.
Angelika Bauer, Cornelia Lass‐Flörl, Stephan Steixner, Oliver Cornely, Ilana Reinhold, Laura Walti, on behalf of International Society for Human and Animal Mycology (ISHAM) Working Group for Patient Representation and Advocacy in Invasive Fungal Infections   +6 more
wiley   +1 more source

Identification of Novel Therapeutic Agent Candidates Through High Throughput Screening With Chemical Library Based on Molecular Subclassification in Canine Histiocytic Sarcoma Cell Lines

Veterinary and Comparative Oncology, Volume 24, Issue 3, Page 554-567, September 2026.
ABSTRACT Effective chemotherapy for canine histiocytic sarcoma (CHS) has yet to be established. In our previous study, CHS cell lines were subclassified into two groups based on their gene expression profiles: Group A and Group B. This study aimed to identify novel therapeutic agents that are effective against each CHS subgroup, and we performed high ...
Hiroki Sakuma, Hirotaka Tomiyasu, Mari Takamiya, Yuko Goto‐Koshino, Atsushi Tsukamoto, Makoto Bonkobara, Masaru Okuda   +6 more
wiley   +1 more source

Population pharmacokinetics of itraconazole

, 2006
Itraconazole is a triazole antifungal used in the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF) and for the prevention of invasive fungal infections in paediatric patients undergoing bone marrow ...
Hennig, Stefanie
core  

Equine Fungal Keratitis due to Cladorrhinum bulbillosum

Veterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective To describe the case details and treatment of an equine fungal keratitis case caused by Cladorrhinum bulbillosum. Animal Studied A 14‐year‐old Bashkir Curly gelding with a complicated corneal ulcer of the left eye. Procedures Corneal cytology was performed, and intraoperative samples were collected for polymerase chain reaction and ...
Abigail Hamilton, Loretta Lacy, Nicole Scherrer   +2 more
wiley   +1 more source

Bilateral Ulcers in Protothecosis: A Diagnostic Challenge

International Journal of Dermatology, Volume 65, Issue 9, Page 1926-1928, September 2026.
Waratchaya Panjapakkul, Charussri Leeyaphan, Penvadee Pattanaprichakul, Kanchalit Thanomkitti, Pattriya Jirawattanadon   +4 more
wiley   +1 more source

Peer review of the pesticide risk assessment of the active substance Beauveria bassiana strain R444

EFSA Journal, Volume 24, Issue 9, September 2026.
Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Denmark, for the pesticide active substance Beauveria bassiana strain R444 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are ...
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Mark Egsmose, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Oriol Magrans, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza   +47 more
wiley   +1 more source

Itraconazole Data (UMH)

Data from composition, characteristics, dissolution and permeability of itraconazole ...
Ruiz-Picazo, Alejandro
core   +1 more source